Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 11/2015

01.11.2015 | Original Article

Aspergillus fumigatus chronic colonization and lung function decline in cystic fibrosis may have a two-way relationship

verfasst von: M. Noni, A. Katelari, G. Dimopoulos, S.-E. Doudounakis, C. Tzoumaka-Bakoula, V. Spoulou

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 11/2015

Einloggen, um Zugang zu erhalten

Abstract

Aspergillus fumigatus is commonly found in cystic fibrosis (CF) airways. Our aim was to assess the relationship between A. fumigatus chronic colonization and lung function in CF patients. A case–control study of CF patients born from 1989 to 2002 was performed. Medical records were reviewed from the time of initial diagnosis until December 2013. Chronic colonization was defined as two or more positive sputum cultures in a given year. Each patient chronically colonized with A. fumigatus was matched with three control patients (never colonized by A. fumigatus) for age, sex, and year of birth (±3 years). A number of parameters were recorded and analyzed prospectively. The primary outcome measure was the difference in forced expiratory volume in 1 s (FEV1) in percent predicted between groups. Linear mixed models were used for longitudinal analyses to evaluate the relationship between A. fumigatus chronic colonization and lung function during a 7-year period and study the lung function 4 years before the time of enrollment (t0). Twenty patients had chronic colonization and were matched with 60 controls. A significant difference in lung function was detected throughout the 7-year period after adjustment for confounders (est = 8.66, p = 0.020). Four years before t0, FEV1 baseline was the only factor associated with the course of lung function (est = 0.64, p < 0.001) and was significantly different between groups (p = 0.001). In conclusion, a decreased FEV1 baseline appears to be a risk factor for chronic colonization by A. fumigatus, which, in turn, may cause a faster deterioration of lung function.
Literatur
5.
Zurück zum Zitat Bargon J, Dauletbaev N, Köhler B, Wolf M, Posselt HG, Wagner TO (1999) Prophylactic antibiotic therapy is associated with an increased prevalence of Aspergillus colonization in adult cystic fibrosis patients. Respir Med 93(11):835–838CrossRefPubMed Bargon J, Dauletbaev N, Köhler B, Wolf M, Posselt HG, Wagner TO (1999) Prophylactic antibiotic therapy is associated with an increased prevalence of Aspergillus colonization in adult cystic fibrosis patients. Respir Med 93(11):835–838CrossRefPubMed
6.
Zurück zum Zitat Burns JL, Van Dalfsen JM, Shawar RM, Otto KL, Garber RL, Quan JM, Montgomery AB, Albers GM, Ramsey BW, Smith AL (1999) Effect of chronic intermittent administration of inhaled tobramycin on respiratory microbial flora in patients with cystic fibrosis. J Infect Dis 179(5):1190–1196. doi:10.1086/314727 CrossRefPubMed Burns JL, Van Dalfsen JM, Shawar RM, Otto KL, Garber RL, Quan JM, Montgomery AB, Albers GM, Ramsey BW, Smith AL (1999) Effect of chronic intermittent administration of inhaled tobramycin on respiratory microbial flora in patients with cystic fibrosis. J Infect Dis 179(5):1190–1196. doi:10.​1086/​314727 CrossRefPubMed
8.
Zurück zum Zitat Noni M, Katelari A, Dimopoulos G, Kourlaba G, Spoulou V, Alexandrou-Athanassoulis H, Doudounakis SE, Tzoumaka-Bakoula C (2014) Inhaled corticosteroids and Aspergillus fumigatus isolation in cystic fibrosis. Med Mycol 52(7):715–722. doi:10.1093/mmy/myu038 CrossRefPubMed Noni M, Katelari A, Dimopoulos G, Kourlaba G, Spoulou V, Alexandrou-Athanassoulis H, Doudounakis SE, Tzoumaka-Bakoula C (2014) Inhaled corticosteroids and Aspergillus fumigatus isolation in cystic fibrosis. Med Mycol 52(7):715–722. doi:10.​1093/​mmy/​myu038 CrossRefPubMed
12.
Zurück zum Zitat Pihet M, Carrere J, Cimon B, Chabasse D, Delhaes L, Symoens F, Bouchara JP (2009) Occurrence and relevance of filamentous fungi in respiratory secretions of patients with cystic fibrosis—a review. Med Mycol 47(4):387–397. doi:10.1080/13693780802609604 CrossRefPubMed Pihet M, Carrere J, Cimon B, Chabasse D, Delhaes L, Symoens F, Bouchara JP (2009) Occurrence and relevance of filamentous fungi in respiratory secretions of patients with cystic fibrosis—a review. Med Mycol 47(4):387–397. doi:10.​1080/​1369378080260960​4 CrossRefPubMed
13.
Zurück zum Zitat Amin R, Dupuis A, Aaron SD, Ratjen F (2010) The effect of chronic infection with Aspergillus fumigatus on lung function and hospitalization in patients with cystic fibrosis. Chest 137(1):171–176. doi:10.1378/chest.09-1103 CrossRefPubMed Amin R, Dupuis A, Aaron SD, Ratjen F (2010) The effect of chronic infection with Aspergillus fumigatus on lung function and hospitalization in patients with cystic fibrosis. Chest 137(1):171–176. doi:10.​1378/​chest.​09-1103 CrossRefPubMed
14.
Zurück zum Zitat Jubin V, Ranque S, Stremler Le Bel N, Sarles J, Dubus JC (2010) Risk factors for Aspergillus colonization and allergic bronchopulmonary aspergillosis in children with cystic fibrosis. Pediatr Pulmonol 45(8):764–771. doi:10.1002/ppul.21240 CrossRefPubMed Jubin V, Ranque S, Stremler Le Bel N, Sarles J, Dubus JC (2010) Risk factors for Aspergillus colonization and allergic bronchopulmonary aspergillosis in children with cystic fibrosis. Pediatr Pulmonol 45(8):764–771. doi:10.​1002/​ppul.​21240 CrossRefPubMed
16.
Zurück zum Zitat Fillaux J, Brémont F, Murris M, Cassaing S, Rittié JL, Tétu L, Segonds C, Abbal M, Bieth E, Berry A, Pipy B, Magnaval JF (2012) Assessment of Aspergillus sensitization or persistent carriage as a factor in lung function impairment in cystic fibrosis patients. Scand J Infect Dis 44(11):842–847. doi:10.3109/00365548.2012.695454 CrossRefPubMed Fillaux J, Brémont F, Murris M, Cassaing S, Rittié JL, Tétu L, Segonds C, Abbal M, Bieth E, Berry A, Pipy B, Magnaval JF (2012) Assessment of Aspergillus sensitization or persistent carriage as a factor in lung function impairment in cystic fibrosis patients. Scand J Infect Dis 44(11):842–847. doi:10.​3109/​00365548.​2012.​695454 CrossRefPubMed
20.
Zurück zum Zitat Tomee JF, Wierenga AT, Hiemstra PS, Kauffman HK (1997) Proteases from Aspergillus fumigatus induce release of proinflammatory cytokines and cell detachment in airway epithelial cell lines. J Infect Dis 176(1):300–303CrossRefPubMed Tomee JF, Wierenga AT, Hiemstra PS, Kauffman HK (1997) Proteases from Aspergillus fumigatus induce release of proinflammatory cytokines and cell detachment in airway epithelial cell lines. J Infect Dis 176(1):300–303CrossRefPubMed
21.
Zurück zum Zitat Amitani R, Taylor G, Elezis EN, Llewellyn-Jones C, Mitchell J, Kuze F, Cole PJ, Wilson R (1995) Purification and characterization of factors produced by Aspergillus fumigatus which affect human ciliated respiratory epithelium. Infect Immun 63(9):3266–3271PubMedCentralPubMed Amitani R, Taylor G, Elezis EN, Llewellyn-Jones C, Mitchell J, Kuze F, Cole PJ, Wilson R (1995) Purification and characterization of factors produced by Aspergillus fumigatus which affect human ciliated respiratory epithelium. Infect Immun 63(9):3266–3271PubMedCentralPubMed
22.
Zurück zum Zitat Mroueh S, Spock A (1994) Allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. Chest 105(1):32–36CrossRefPubMed Mroueh S, Spock A (1994) Allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. Chest 105(1):32–36CrossRefPubMed
26.
Zurück zum Zitat Paugam A, Baixench M-T, Demazes-Dufeu N, Burgel P-R, Sauter E, Kanaan R, Dusser D, Dupouy-Camet J, Hubert D (2010) Characteristics and consequences of airway colonization by filamentous fungi in 201 adult patients with cystic fibrosis in France. Med Mycol 48(Suppl 1):S32–S36. doi:10.3109/13693786.2010.503665 CrossRefPubMed Paugam A, Baixench M-T, Demazes-Dufeu N, Burgel P-R, Sauter E, Kanaan R, Dusser D, Dupouy-Camet J, Hubert D (2010) Characteristics and consequences of airway colonization by filamentous fungi in 201 adult patients with cystic fibrosis in France. Med Mycol 48(Suppl 1):S32–S36. doi:10.​3109/​13693786.​2010.​503665 CrossRefPubMed
27.
Zurück zum Zitat Hodson ME, Gallagher CG, Govan JR (2002) A randomised clinical trial of nebulised tobramycin or colistin in cystic fibrosis. Eur Respir J 20(3):658–664CrossRefPubMed Hodson ME, Gallagher CG, Govan JR (2002) A randomised clinical trial of nebulised tobramycin or colistin in cystic fibrosis. Eur Respir J 20(3):658–664CrossRefPubMed
29.
Zurück zum Zitat de Valk HA, Klaassen CH, Yntema JB, Hebestreit A, Seidler M, Haase G, Müller FM, Meis JF (2009) Molecular typing and colonization patterns of Aspergillus fumigatus in patients with cystic fibrosis. J Cyst Fibros 8(2):110–114. doi:10.1016/j.jcf.2008.10.003 CrossRefPubMed de Valk HA, Klaassen CH, Yntema JB, Hebestreit A, Seidler M, Haase G, Müller FM, Meis JF (2009) Molecular typing and colonization patterns of Aspergillus fumigatus in patients with cystic fibrosis. J Cyst Fibros 8(2):110–114. doi:10.​1016/​j.​jcf.​2008.​10.​003 CrossRefPubMed
30.
Zurück zum Zitat Cimon B, Symoens F, Zouhair R, Chabasse D, Nolard N, Defontaine A, Bouchara JP (2001) Molecular epidemiology of airway colonisation by Aspergillus fumigatus in cystic fibrosis patients. J Med Microbiol 50(4):367–374CrossRefPubMed Cimon B, Symoens F, Zouhair R, Chabasse D, Nolard N, Defontaine A, Bouchara JP (2001) Molecular epidemiology of airway colonisation by Aspergillus fumigatus in cystic fibrosis patients. J Med Microbiol 50(4):367–374CrossRefPubMed
31.
Zurück zum Zitat Neuvéglise C, Sarfati J, Debeaupuis JP, Vu Thien H, Just J, Tournier G, Latgé JP (1997) Longitudinal study of Aspergillus fumigatus strains isolated from cystic fibrosis patients. Eur J Clin Microbiol Infect Dis 16(10):747–750CrossRefPubMed Neuvéglise C, Sarfati J, Debeaupuis JP, Vu Thien H, Just J, Tournier G, Latgé JP (1997) Longitudinal study of Aspergillus fumigatus strains isolated from cystic fibrosis patients. Eur J Clin Microbiol Infect Dis 16(10):747–750CrossRefPubMed
32.
Zurück zum Zitat Verweij PE, Meis JF, Sarfati J, Hoogkamp-Korstanje JA, Latgé JP, Melchers WJ (1996) Genotypic characterization of sequential Aspergillus fumigatus isolates from patients with cystic fibrosis. J Clin Microbiol 34(10):2595–2597PubMedCentralPubMed Verweij PE, Meis JF, Sarfati J, Hoogkamp-Korstanje JA, Latgé JP, Melchers WJ (1996) Genotypic characterization of sequential Aspergillus fumigatus isolates from patients with cystic fibrosis. J Clin Microbiol 34(10):2595–2597PubMedCentralPubMed
33.
Zurück zum Zitat Simmonds EJ, Littlewood JM, Hopwood V, Evans EG (1994) Aspergillus fumigatus colonisation and population density of place of residence in cystic fibrosis. Arch Dis Child 70(2):139–140PubMedCentralCrossRefPubMed Simmonds EJ, Littlewood JM, Hopwood V, Evans EG (1994) Aspergillus fumigatus colonisation and population density of place of residence in cystic fibrosis. Arch Dis Child 70(2):139–140PubMedCentralCrossRefPubMed
Metadaten
Titel
Aspergillus fumigatus chronic colonization and lung function decline in cystic fibrosis may have a two-way relationship
verfasst von
M. Noni
A. Katelari
G. Dimopoulos
S.-E. Doudounakis
C. Tzoumaka-Bakoula
V. Spoulou
Publikationsdatum
01.11.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 11/2015
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-015-2474-y

Weitere Artikel der Ausgabe 11/2015

European Journal of Clinical Microbiology & Infectious Diseases 11/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.